Quantcast
Last updated on April 24, 2014 at 10:25 EDT

Latest glioblastoma multiforme Stories

2013-11-06 08:30:00

SYDNEY, Nov. 6, 2013 /PRNewswire/ -- Novogen Limited (Australian Securities Exchange: NRT and NASDAQ: NVGN), an Australian biotechnology company dedicated to developing drugs that provide long-term remission through the successful control of cancer stem cells, today announced a joint venture with Yale University dedicated to developing personalized approaches to chemotherapy to fight ovarian cancer. The joint venture, which will be based near Yale's campus in New Haven, CT, will be...

2013-11-05 10:55:56

Study confirms that vascular normalization is the way these drugs improve patient survival Advanced imaging techniques may be able to distinguish which patients' tumors will respond to treatment with anti-angiogenic drugs and which will not. In patients newly diagnosed with the dangerous brain tumor glioblastoma, Massachusetts General Hospital (MGH) researchers report, those for whom treatment with the anti-angiogenic drug cediranib rapidly 'normalized' abnormal blood vessels around their...

2013-11-05 08:36:35

The NovoTAL System Enables Certified Physicians to Plan and Individualize NovoTTF(TM) Therapy for Recurrent Glioblastoma Patients NEW YORK, Nov. 5, 2013 /PRNewswire/ -- Novocure announced today that the United States Food and Drug Administration (FDA) has approved the NovoTAL (Transducer Array Layout) System through a Premarket Approval (PMA) supplement. The NovoTAL System allows certified physicians to use the individual MRI data of recurrent glioblastoma multiforme (GBM) patients...

2013-11-01 23:24:31

Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, commends researchers at the Washington University School of Medicine for their identification of a biological marker that may help predict survival in patients with deadly brain cancers. New York, NY (PRWEB) November 01, 2013 Voices Against Brain Cancer commends Washington University School of Medicine researchers for identifying a protein that may give scientists better insight into more...

2013-10-29 23:28:05

The conference brought together patients and caregivers from all over the nation, as well as national brain tumor experts including Dr. Patrick Wen of the Dana-Farber Cancer Institute. Seattle, WA (PRWEB) October 29, 2013 The Chris Elliott Fund (CEF) hosted the second annual Brains Matter Patient and Caregiver Conference and Awareness Day, on Friday, September 27th at the Bellevue Club in Bellevue, WA. This conference was available for patients and caregivers affected by brain cancer...

2013-10-21 08:29:07

VAL-083 therapeutic activity seen in glioblastoma, chronic myelogenous leukemia and non-small cell lung cancer VANCOUVER, British Columbia and MENLO PARK, Calif., Oct. 21, 2013 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" and "DelMar Pharma") today announced the presentation of data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics Annual Meeting. The data presented today, along with historical research by the U.S....

2013-10-18 23:02:37

The 6th Annual Turning up the Heat for Brain Tumors Chili Cook-off in Lake Mary, FL raises funds and awareness for the Chris Elliott Fund. Lake Mary, FL (PRWEB) October 18, 2013 This year marks the 6th Annual Turning Up the Heat on Brain Tumors Chili Cook-off to raise money for brain cancer patient support and research for the Chris Elliott Fund. The cook-off will be held at the Mike Bender Golf Academy, at the Magnolia Plantation Golf Club in Lake Mary, Florida on Sunday, November 10th,...

2013-10-16 09:21:11

Parvoviruses cause no harm in humans, but they can attack and kill cancer cells. Since 1992, scientists at the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) have been studying these viruses with the aim of developing a viral therapy to treat glioblastomas, a type of aggressively growing brain cancer. A clinical trial has been conducted since 2011 at the Heidelberg University Neurosurgery Hospital to test the safety of treating cancer patients with the parvovirus H-1....

2013-10-09 08:27:04

Glioblastoma multiforme (GBM) Phase 1b clinical trial is ongoing for VAL-083, a chemotherapy that has been well-studied by the National Institutes of Health VANCOUVER, British Columbia and MENLO PARK, Calif., Oct. 9, 2013 /PRNewswire/ -- The president and CEO of DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar Pharma" or "DelMar") Jeffrey Bacha spoke to Life Science IP Review (LSIPR) about developing new intellectual property (IP) for their lead drug candidate, VAL-083, a new therapy in...

2013-10-08 13:17:08

A major study conducted at the Sahlgrenska Academy has now disproved theories of a viral cause for breast cancer and the brain tumor, glioblastoma. The study, which was based on over seven billion DNA sequences and which is published in Nature Communications, found no genetic traces of viruses in these forms of cancer. It has been scientifically proven that about 15 per cent of all cancer cases are the result of viral infection, but many researchers believe that even more cancers could be...